Literature DB >> 20357319

The influence of the size of the component on the outcome of resurfacing arthroplasty of the hip: a review of the literature.

A J Shimmin1, W L Walter, C Esposito.   

Abstract

The survivorship of contemporary resurfacing arthroplasty of the hip using metal-on-metal bearings is better than that of first generation designs, but short-term failures still occur. The most common reasons for failure are fracture of the femoral neck, loosening of the component, osteonecrosis of the femoral head, reaction to metal debris and malpositioning of the component. In 2008 the Australian National Joint Registry reported an inverse relationship between the size of the head component and the risk of revision in resurfacing hip arthroplasty. Hips with a femoral component size of </= 44 mm have a fivefold increased risk of revision than those with femoral components of >/= 55 mm irrespective of gender. We have reviewed the literature to explore this observation and to identify possible reasons including the design of the implant, loading of the femoral neck, the orientation of the component, the production of wear debris and the effects of metal ions, penetration of cement and vascularity of the femoral head. Our conclusion is that although multifactorial, the most important contributors to failure in resurfacing arthroplasty of the hip are likely to be the design and geometry of the component and the orientation of the acetabular component.

Entities:  

Mesh:

Year:  2010        PMID: 20357319     DOI: 10.1302/0301-620X.92B4.22967

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  17 in total

1.  High revision rate at 5 years after hip resurfacing with the Durom implant.

Authors:  Florian D Naal; Ronny Pilz; Urs Munzinger; Otmar Hersche; Michael Leunig
Journal:  Clin Orthop Relat Res       Date:  2011-01-29       Impact factor: 4.176

2.  Assessment of inter- and intra-observer reliability in the determination of radiographic version and inclination of the cup in metal-on-metal hip resurfacing.

Authors:  Aleksi Reito; Timo Puolakka; Antti Paakkala; Jorma Pajamäki
Journal:  Int Orthop       Date:  2011-08-12       Impact factor: 3.075

Review 3.  [Results of 5 to 10-year follow-up after hip resurfacing. A systematic analysis of the literature on long-term results].

Authors:  M C M Klotz; S J Breusch; M Hassenpflug; R G Bitsch
Journal:  Orthopade       Date:  2012-06       Impact factor: 1.087

4.  [Approach to painful hip resurfacing].

Authors:  L Gerdesmeyer; H Gollwitzer; P Diehl; M Fuerst; M Schmitt-Sody
Journal:  Orthopade       Date:  2011-06       Impact factor: 1.087

5.  Metal ion levels comparison: Metal-on-metal hip resurfacing vs total hip arthroplasty in patients requiring revision surgery.

Authors:  Syed S Ahmed; Rajesh Bawale; Sunil Jain; Srinivas Samsani
Journal:  J Orthop       Date:  2018-09-28

6.  Are There Long-term Benefits to Cementing the Metaphyseal Stem in Hip Resurfacing?

Authors:  Harlan C Amstutz; Michel J Le Duff; Sandeep K Bhaurla
Journal:  Clin Orthop Relat Res       Date:  2015-06-23       Impact factor: 4.176

7.  Insufficient acetabular version increases blood metal ion levels after metal-on-metal hip resurfacing.

Authors:  Alister J Hart; John A Skinner; Johann Henckel; Barry Sampson; Fabiana Gordon
Journal:  Clin Orthop Relat Res       Date:  2011-06-09       Impact factor: 4.176

Review 8.  The future role of metal-on-metal hip resurfacing.

Authors:  Gulraj S Matharu; Hemant G Pandit; David W Murray; Ronan B C Treacy
Journal:  Int Orthop       Date:  2015-02-24       Impact factor: 3.075

Review 9.  Metal-on-metal hip resurfacing arthroplasty: an analysis of safety and revision rates.

Authors:  S Sehatzadeh; K Kaulback; L Levin
Journal:  Ont Health Technol Assess Ser       Date:  2012-08-01

10.  Metal-on-metal hip resurfacing: correlation between clinical and radiological assessment, metal ions and ultrasound findings.

Authors:  M Scaglione; L Fabbri; N Bianchi; D Dell'Omo; G Guido
Journal:  Musculoskelet Surg       Date:  2014-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.